Computer glitch in insulin pumps hits MiniMed shares
This article was originally published in Clinica
MiniMed has warned that a software error in some of its insulin pumps could lead to unreliable insulin dosing. The company said that only certain of its Model 508 pumps, manufactured between October 4 and November 18, are affected. The fault will cost the company up to $1.5 million to upgrade the relevant software. MiniMed saw more than $10 wiped from its share price on the announcement, with its shares ending early last Tuesday at $79.20.
You may also be interested in...
Butterfly Network chose SPAC route with Longview Acquisition Corp. to scale its business and expand into the home market in 2021.
Regulatory review resource-intensive cell and gene therapy licensing applications are rolling toward US FDA along expedited pathways, while complete response letters and missed goal dates start to stack up under pandemic inspection constraints.
With Warp Speed Decisions Already Made, Transitioning To Biden Admin Should Be No Trouble, Slaoui Says
As vaccines near availability, Moncef Slaoui says his full-time role at OWS may be ending. He has not met with the Biden Transition team, but notes that other Warp Speed officials have.